Neuro-oncology practice clinical debate: Long-term antiepileptic drug prophylaxis in patients with glioma

Brian Stocksdale, Seema Nagpal, John D. Hixson, Derek R. Johnson, Prashant Rai, Akhil Shivaprasad, Ivo W. Tremont-Lukats

Research output: Contribution to journalArticlepeer-review

Abstract

Patients with primary brain tumors often experience seizures, which can be the presenting symptom or occur for the first time at any point along the illness trajectory. In addition to causing morbidity, seizures negatively affect independence and quality of life in other ways, for example, by leading to loss of driving privileges. Long-term therapy with antiepileptic drugs (AEDs) is the standard of care in brain tumor patients with seizures, but the role of prophylactic AEDs in seizure-naive patients remains controversial. In this article, experts in the field discuss the issues of AED efficacy and toxicity, and explain their differing recommendations for routine use of prophylactic AEDs.

Original languageEnglish (US)
Pages (from-to)583-588
Number of pages6
JournalNeuro-Oncology Practice
Volume7
Issue number6
DOIs
StatePublished - Dec 1 2020
Externally publishedYes

Keywords

  • Antiepileptic
  • Brain tumor
  • Glioma
  • Prophylaxis
  • Seizure

ASJC Scopus subject areas

  • Medicine (miscellaneous)

Fingerprint Dive into the research topics of 'Neuro-oncology practice clinical debate: Long-term antiepileptic drug prophylaxis in patients with glioma'. Together they form a unique fingerprint.

Cite this